This article is more than 5 years old. Information may no longer be current.

VIDEO: Spark Therapeutics announces genetic testing initiative

Issue: November 25, 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — At the Ophthalmology Innovation Summit here, Jeffrey D. Marrazzo, chief executive officer of Spark Therapeutics, discusses a new initiative by Spark to provide physicians and patients access to genetic testing for more than 30 genes linked to certain forms of inherited retinal diseases. The initiative is called the Identify Your Inherited Retinal Disease, or ID YOUR IRD.